Alkermes Inc. plans to seek approval next year to market its Vivitrol drug to treat opioid dependence, based on the results of a clinical trial. Cambridge-based Alkermes develops Vivitrol to treat alcoholism.
Tags: based-on-the, clinical-trial, results, vivitrol